SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203101. A total of 15 filers reported holding SOLENO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 14,695,264 | $7,642,000 | 1.54% |
| Palo Alto Investors LP | 84,748 | $220,000 | 0.01% |
| 683 Capital Management, LLC | 150,000 | $78,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 44,230 | $23,000 | 0.00% |
| Virtu Financial LLC | 52,942 | $28,000 | 0.00% |
| VANGUARD GROUP INC | 202,427 | $105,000 | 0.00% |
| NORTHERN TRUST CORP | 14,376 | $7,000 | 0.00% |
| ROYAL BANK OF CANADA | 7 | $0 | 0.00% |
| UBS Group AG | 16,718 | $9,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 10,170 | $5,000 | 0.00% |